Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)
Health Care · Pharmaceuticals · BD
Tk752.00
+1.43% today · -6.4% 1Y
Ambee Pharmaceuticals PLC (DSE: AMBEEPHA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.65M.
Over the last twelve months the share price has lost 6.4%, trading between 681.00 and 847.00.
Tweenvest scores Ambee Pharmaceuticals PLC across four factors: quality 49/100, value 16/100, growth 0/100, dividend 3/100. Its strongest factor is quality.
AMBEEPHA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.65M
- Revenue (TTM)
- $1.29M
- P/E
- —
- EPS
- 2.30
- Dividend yield
- 0.13%
- Beta (5Y)
- -0.22
- 52-week high
- Tk847.00
- 52-week low
- Tk681.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.40M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
| Union Korea Pharm Co., Ltd.KOSDAQ: A080720 | $14.59M | ₩— | — |
| Biofrontera Inc.NasdaqCM: BFRI | $14.41M | $0.94 | -3.51% |
| Bio Essence CorporationOTCPK: BIOE | $14.37M | $0.27 | — |
Figures last refreshed Oct 11, 2026.